Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Literature
1.
Kersten HM, Roxburgh RH, Child N, Polkinghorne PJ, Frampton C, Danesh-Meyer HV (2014) Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1. J Neurol 261(1):37–44CrossRefPubMed
2.
Choi SH, Yang HK, Hwang JM, Park KS (2016) Ocular findings of myotonic dystrophy type 1 in the Korean population. Graefes Arch Clin Exp Ophthalmol 254(6):1189–1193CrossRefPubMed
3.
Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, Hee MR, Flotte T, Gregory K, Puliafito CA et al (1991) Optical coherence tomography. Science 254(5035):1178–1181CrossRefPubMedPubMedCentral
4.
Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293(5531):864–867CrossRefPubMed
5.
Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B (2011) Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Genet 19(7):776–782CrossRefPubMedPubMedCentral
6.
7.
Fraser-Bell S, Guzowski M, Rochtchina E, Wang JJ, Mitchell P (2003) Five-year cumulative incidence and progression of epiretinal membranes: the Blue Mountains Eye Study. Ophthalmology 110(1):34–40CrossRefPubMed
8.
Watanabe A, Arimoto S, Nishi O (2009) Correlation between metamorphopsia and epiretinal membrane optical coherence tomography findings. Ophthalmology 116(9):1788–1793CrossRefPubMed
9.
Turner C, Hilton-Jones D (2010) The myotonic dystrophies: diagnosis and management. J Neurol Neurosurg Psychiatry 81(4):358–367CrossRefPubMed
10.
Hayasaka S, Kiyosawa M, Katsumata S, Honda M, Takase S, Mizuno K (1984) Ciliary and retinal changes in myotonic dystrophy. Arch Ophthalmol 102(1):88–93CrossRefPubMed
11.
Kimizuka Y, Kiyosawa M, Tamai M, Takase S (1993) Retinal changes in myotonic dystrophy: clinical and follow-up evaluation. Retina 13(2):129–135CrossRefPubMed
12.
Rosa N, Lanza M, Borrelli M, De Bernardo M, Palladino A, Di Gregorio MG, Pascotto F, Politano L (2011) Low intraocular pressure resulting from ciliary body detachment in patients with myotonic dystrophy. Ophthalmology 118(2):260–264CrossRefPubMed
13.
Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60(4):657–664CrossRefPubMed
14.
Ghazi-Nouri SMS, Tranos PG, Rubin GS, Adams ZC, Charteris DG (2006) Visual function and quality of life following vitrectomy and epiretinal membrane peel surgery. Br J Ophthalmol 90(5):559–562CrossRefPubMedPubMedCentral
Metadata
Title
Ophthalmic findings in myotonic dystrophy type 2: a case series
Authors
Hannah M. Kersten
Helen V. Danesh-Meyer
Richard H. Roxburgh
Publication date
01-12-2016
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 12/2016
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-016-8325-7

Other articles of this Issue 12/2016

Journal of Neurology 12/2016 Go to the issue

Letter to the Editors

Low testosterone and myasthenia gravis in males: a national record-linkage study

Neurological Update

Neurogenic lower urinary tract dysfunction: evaluation and management

Letter to the Editors

Familial paraganglioma syndrome: a rare cause of carotid artery occlusion

Original Communication

External validation of a 3-step falls prediction model in mild Parkinson’s disease

Journal club

What can rare variant genetics tell us about cognition and intellectual difficulties?

Original Communication

Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy